← Eichor
Study identifier: NCT07403201 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Therapy Combination in PCOS With Dlbs 3233

Condition: Polycystic Ovary Syndrome  ·  Sponsor: Inlacinpenelitian

PhaseEARLY_Phase 1
Planned participants90
Who can joinFemale, N/A to 45 Years
Healthy volunteersNo

About this study

The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital

This description comes directly from the study's public registry record.

Talk to the study team

prastika candra, s1  ·  62882003145445  ·  prastikacandra13@gmail.com

nazdifah fitriyani, s1  ·  6282223338737  ·  nadzifahfitri37@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

RS AMC YogyakartaYogyakarta, DIY, IndonesiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07403201